Skip to main content
    Q

    Quantum BioPharma Ltd. (QNTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.59
    +0.15 (+10.42%)

    Market Cap: $9.26M

    Last updated: Nov 17, 2026 at 4:31 PM ET

    Quantum BioPharma Ltd. (QNTM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Quantum BioPharma (QNTM) has a market cap of $9.26M and an enterprise value of $6.63M. Its share count is up 109.97% from a year earlier. It holds $2.63M more cash than debt, 28.43% of its market cap.

    Total Valuation

    Enterprise value is 28.43% below the market cap, as cash exceeds debt.

    Market Cap$9.26M
    Enterprise Value$6.63M
    Latest price (Nov 17, 2026)$1.59

    Key Dates

    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 20.00% in the quarter ended Sep 30, 2026 and grew 194.89% a year over 2 years.

    Shares Outstanding7.98M
    Shares Change (YoY)+109.97%
    Shares Change (QoQ)+20.00%
    Share Count Growth (2Y CAGR)+194.89%

    Price Statistics

    The stock is down 78.40% over 52 weeks and trades 43.82% below its 50-day average.

    Beta (1Y)0.53
    52-Week Change-78.40%
    1-Month Change-34.02%
    3-Month Change-54.83%
    6-Month Change-77.29%
    5-Year Change-97.36%
    Total Return (1Y)-78.40%
    Total Return (3Y CAGR)-72.44%
    Total Return (5Y CAGR)-56.01%
    Return vs SPY (1Y)-88.14%
    Max Drawdown (1Y)-87.38%
    Max Drawdown (3Y)-98.36%
    Sharpe Ratio (1Y)-1.08
    Correlation with SPY (1Y)0.05
    50-Day Average$2.83
    200-Day Average$3.65
    52-Week Range$1.33 to $12.42
    RSI (14 Days)27.3
    Average Volume (20 Days)104.28K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.72x current liabilities, and total debt is 0.08x shareholder equity.

    Current Ratio1.72x
    Quick Ratio1.72x
    Debt / Equity0.08x
    Interest Coverage-52.98x

    Returns and Efficiency

    Return on invested capital is -150.11% over the last 12 months.

    Return on Assets (ROA)-143.60%
    Return on Invested Capital (ROIC)-150.11%
    Inventory Turnover19.86x

    Scores

    QNTM has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Balance Sheet

    Cash and Equivalents$3.56M
    Total Debt$923.83K
    Net Cash$2.63M
    Net Cash Per Share$0.33

    Balance sheet as of Sep 30, 2026.

    Stock Splits

    The last split was a 1-for-65 reverse split on Aug 15, 2024.

    Last Split DateAug 15, 2024
    Split TypeReverse split
    Split Ratio1:65

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About QNTM

    What is QNTM's market cap?

    Quantum BioPharma has a market cap of $9.26M. Its enterprise value, which adds debt and subtracts cash, is $6.63M.

    How many shares of QNTM are outstanding?

    Quantum BioPharma has 7.98M shares outstanding. The count is up 109.97% from a year earlier.

    Does QNTM pay a dividend?

    No. Quantum BioPharma does not pay a dividend.

    How much debt does QNTM have?

    Quantum BioPharma has $923.83K of total debt and $3.56M of cash and equivalents, a net cash position of $2.63M.